siRNA, Anti-BTN2A1, 2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT36314WQ-2OMe)

The product SIRGT36314WQ-2OMe is a type of small interfering RNA (siRNA) that targets BTN2A1 gene and regulates the expression of gene. The siRNA interferes with the expression of BTN2A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001197233.2; NM_001197234.2; NM_007049.4; NM_078476.3
Alternative Names BK14H9.1; BT2.1; BTF1; BTN2.1; DJ3E1.1
Related Diseases Butyrophilin (BTN) family interactions
Purification HPLC
Target Gene
Gene ID 11120
Uniprot ID Q7KYR7
Sub Cat Target Species Modification Scale  
SIRGT38314WQ-2MOE BTN2A1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT36314WQ-RB BTN2A1 Human Ribo-modified Inquiry
SIRGT37314WQ-BB BTN2A1 Human Backbone-modified Inquiry

Related Products